News French court overturns €444m fine for Novartis, Roche Says companies did not abuse a market position to push Lucentis over off-label Avastin in AMD.
News Daiichi Sankyo wins round in Enhertu patent dispute US PTO has agreed to take another look at whether Seagen's '039 patent is valid.
News CMS eyes lower prices for drugs with accelerated approval Approach could cut medicine costs and curb delays in confirmatory trials, says agency
News Changing Faces: Agency and investor hires in Dec and Jan December and January had their share of hires in marketing and comms, and an investor hire too.
News Changing Faces: Pharma-adjacent hires in Dec ’22 and Jan ’23 December and January also saw hires in digital health companies and pharm-adjacent industries
News 5 reasons AZ may be siting its new plant in Ireland, not UK AstraZeneca's revelation in its fourth-quarter results update - that it had decided to build a new $360 million manufacturing facility in Ireland, rather than its home ter
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
